WCMNY
XENT

Westchester Capital Management (New York)’s Intersect ENT, Inc XENT Stock Holding History

Westchester Capital Management (New York)’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-811,852
Closed -$22.7M – 470
2022
Q1 		$22.7M Buy
811,852
+185,979
+30% +$5.1M 0.62% 36
2021
Q4 		$17.1M Buy
625,873
+428,163
+217% +$11.6M 0.49% 30
2021
Q3 		$5.38M Buy
+197,710
New +$4.89M 0.15% 91

Westchester Capital Management (New York)'s XENT Position: Q2 2022 in Review

Westchester Capital Management (New York) sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 811,852 shares — an estimated $22.7M sold.

Westchester Capital Management (New York) first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $22.7M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Westchester Capital Management (New York) reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 811,852 Intersect ENT, Inc shares in Q2 2022, an estimated $22.7M.
  • Westchester Capital Management (New York) first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
  • Westchester Capital Management (New York)'s Intersect ENT, Inc position peaked at $22.7M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.